Kim Monkhorst

The Netherlands Cancer Institute

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Collaborators (7)

Robert Rintoul

Professor of Thoracic Oncology

University of Cambridge

UNITED KINGDOM

Koen Hartemink

Universitair Medisch Centrum Utrecht

Joachim G. Aerts

Michel M. van den Heuvel

Radboud University Medical Center

Eva Madsen

Erasmus University Rotterdam

Tijmen van der Wel

Leiden University Medical Center

Egbert Smit

Leiden University Medical Center

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kim Monkhorst

Research Interests

Explore related searches

Contact this professor

Articles (14)

Collaborators (7)

Robert Rintoul

Koen Hartemink

Joachim G. Aerts

Michel M. van den Heuvel

Eva Madsen

Tijmen van der Wel

Egbert Smit

Make your next move.

Kim Monkhorst

Research Interests

Explore related searches

Contact this professor

Articles (14)

The role of whole-genome sequencing for guiding systemic therapy in patients with soft tissue sarcoma

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study

Tremelimumab plus Durvalumab prior to Chemoradiotherapy in Unresectable, Locally Advanced Non–Small Cell Lung Cancer: The Induction Trial

Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study

Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer

Combining Genomic Biomarkers to Guide Immunotherapy in Non–Small Cell Lung Cancer

Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers

Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer

Real-World Utilization of Biomarker Testing for Patients with Advanced Non–Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals

A Serum Protein Classifier Identifying Patients with Advanced Non–Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors

Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice

Collaborators (7)

Robert Rintoul

Koen Hartemink

Joachim G. Aerts

Michel M. van den Heuvel

Eva Madsen

Tijmen van der Wel

Egbert Smit

Make your next move.